AKTS (AKTS) Stock Price & Analysis
AKTS (AKTS) rose 1.50% to USD 27.05 as of September 8, 2026 at 12:50 UTC, according to Nexqual real-time market data.
AKTS last closed at USD 27.05; the session ranged USD 26.18–27.2 on volume of 159,248 shares. Market capitalization is —, with a 52-week range of USD 14.72–34.19 (NMS). Source: Nexqual, September 8, 2026 at 12:50 UTC.
Key Statistics (as of September 8, 2026 at 12:50 UTC)
| Price | USD 27.05 |
|---|---|
| Change | ▲ 1.50% (up) |
| Previous Close | USD 27.05 |
| Open | USD 27.05 |
| Day Range | USD 26.18 – 27.2 |
| 52-Week Range | USD 14.72 – 34.19 |
| Volume | 159,248 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (AKTS)
Nexqual's technical model rates AKTS "BUY" based on 5 bullish and 1 bearish signals across 128 daily candles, as of September 8, 2026 at 12:50 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 62.03 (neutral) |
| vs SMA50 | Above (USD 25.59) |
| MACD | 0.64 (positive) |
From AKTS's Latest SEC 10-K Filing (filed 2026-03-30)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SPRO | Spero Therapeutics, Inc. | USD 1.21 | ▼ 0.82% |
| DTIL | Precision BioSciences, Inc. | USD 7.47 | ▲ 0.27% |
| INSG | Inseego Corp. | USD 4.24 | ▲ 1.68% |
| AIRG | Airgain, Inc. | USD 5.25 | ▲ 4.58% |
| ATOM | Atomera Incorporated | USD 4.04 | ▲ 1% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 12:50 UTC. This page is informational and not investment advice.